Form 4: SenesTech Director Moss Acquires Stock Options
SEC Form 4 Filing
Director Joshua Matthew Moss acquired stock options in SenesTech, Inc. on January 8, 2025.
Summary
- On January 8, 2025, Joshua Matthew Moss, a director of SenesTech, Inc., acquired stock options.
- The options grant Moss the right to buy 8,057 shares of common stock at an exercise price of $3.16 per share.
- The options vest in three tranches, with 1/3 vesting on February 27, 2025, May 27, 2025, and August 27, 2025.
- Full vesting occurs on the earlier of August 27, 2025, or the first annual meeting of stockholders after the grant date, contingent on continued service to the company.
- Following the transaction, Moss directly owns 8,057 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to a director. While insider ownership can be a positive signal, this specific event is more procedural.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
This is a standard regulatory filing related to insider transactions. It's common for directors and officers to receive stock options as part of their compensation packages.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation across various industries.
- The vesting schedule and exercise price would need to be compared to similar companies in the biotechnology or pest control sectors to determine if they are in line with industry standards.
- Companies like Bayer, BASF, and Corteva Agriscience also utilize stock options as part of their compensation packages.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 01/08/2025 | Date of stock option transaction |
| 01/10/2025 | Date of Form 4 filing |
| 02/27/2025 | First vesting date for 1/3 of the stock options |
| 05/27/2025 | Second vesting date for 1/3 of the stock options |
| 08/27/2025 | Final vesting date for 1/3 of the stock options or the first annual meeting of stockholders after the grant date |
| 01/08/2035 | Expiration date of the stock options |
Keywords
stock options, Form 4, director, SENES, SenesTech, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.